Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presence of risk factors
- asymptomatic
Outros fatores diagnósticos
- cervical discharge
- friable cervix
- abnormal vaginal bleeding
- penile discharge
- vaginal discharge
- dysuria
- pelvic pain
- fever/chills
- nausea/vomiting
- scrotal pain
- myalgias
- abdominal pain
- mucopurulent rectal discharge or tenesmus
- joint pain and swelling
- eye irritation
- rashes
- inflammation
Fatores de risco
- age under 25 years, sexually active
- new sex partner or multiple sex partners
- sexual activity with infected partner
- condoms not used
- history of prior STI
- ethnicity
- urban residence and low socio-economic status
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- nucleic acid amplification test (NAAT)
Investigações a serem consideradas
- direct immunofluorescence
- enzyme immunoassay
- nucleic acid hybridisation tests
- cell culture
Novos exames
- rapid and point-of-care tests
Algoritmo de tratamento
confirmed or suspected
Colaboradores
Autores
Matthew M. Hamill, MBChB, PhD, FRCP
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore
MD
Declarações
MMH receives royalties for contributing to UpToDate on Lymphogranuloma venereum and for Clinical Care Options. He has an honorarium from Roche Diagnostics for panel STI & HIV 2021 World Congress (virtual) and was a member of the 2021 Roche group on future of POCT for STI. He has also received consulting fees from GSK for the HSV vaccine.
Agradecimentos
Dr Matthew M. Hamill would like to gratefully acknowledge Dr Anne Rompalo and Dr Christopher K. Fairley, the previous contributors to this topic.
Declarações
AR and CKF declare that they have no competing interests.
Revisores
Kenneth Lin, MD
Assistant Editor
American Family Physician
Clinical Assistant Professor
GUSOM Medical Officer
US Preventive Services Task Force
Declarações
KL declares that he has no competing interests.
Lars Jørgen Østergaard, MD, PhD, DMSc
Professor/Head
Department of Infectious Diseases
Aarhus University Hospital
Skejby Sygehus
Aarhus
Denmark
Declarações
LJO has been funded by Pfizer to write a leaflet on Chlamydia infections.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referências
Principais artigos
Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016 Mar;27(4):251-67.Texto completo Resumo
Centers for Disease Control and Prevention. Sexually transmitted infections surveillance, 2023. Nov 2024 [internet publication].Texto completo
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Texto completo Resumo
US Preventive Services Task Force. Final recommendation statement. Chlamydia and gonorrhea: screening. Sept. 2021 [internet publication].Texto completo
Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24;373(26):2512-21.Texto completo Resumo
American College of Obstetricians and Gynecologists. Committee opinion no. 737: expedited partner therapy. Jun 2018 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Lymphogranuloma venereum
- Gonorrhoea infection
- Bacterial vaginosis
Mais Diagnósticos diferenciaisDiretrizes
- 2025 European guideline on the management of Chlamydia trachomatis infections
- Reducing sexually transmitted infections
Mais DiretrizesFolhetos informativos para os pacientes
Chlamydia
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal